Zai Lab (ZLAB) Enterprise Value (2017 - 2026)
Zai Lab (ZLAB) posted Enterprise Value of -$751.3 million for Q1 2026, up 3.62% sequentially from -$779.6 million in Q4 2025, and up 12.36% YoY from -$668.7 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Enterprise Value (2017 - 2026) Analysis & Trends
Zai Lab has reported Enterprise Value for 11 years, with the latest figure at -$751.3 million in Q1 2026.
- Quarterly Enterprise Value rose 12.36% year-over-year to -$751.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$751.3 million (up 12.36% YoY) and the FY2025 annual result came in at -$779.6 million, changed 0.01% from the prior year.
- Enterprise Value advanced to -$751.3 million in Q1 2026 per ZLAB's latest filing, from -$779.6 million in the prior quarter.
- Over five years, Enterprise Value peaked at -$716.1 million in Q3 2024 and troughed at -$1.3 billion in Q1 2022.
- A 5-year average of -$890.7 million and a median of -$820.4 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2023: Enterprise Value decreased 29.49% in 2022, then soared 30.37% in 2023.
- Over 5 years, Enterprise Value stood at -$1.0 billion in 2022, then advanced by 20.03% to -$806.5 million in 2023, then climbed by 3.32% to -$779.7 million in 2024, then rose by 0.01% to -$779.6 million in 2025, then climbed by 3.62% to -$751.3 million in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$751.3 million, -$779.6 million, and -$817.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.78 Bn | 130.92 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.50 Bn | 77.51 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn |
| 4 | Moderna | 58.06 Bn | 52.92 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - |
| 6 | BeOne Medicines | 40.04 Bn | 34.94 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.41 Bn | 27.57 Bn | - |
| 9 | Insmed | 27.42 Bn | 26.26 Bn | 358.27 Mn |
| 10 | Zai Lab | 2.93 Bn | 2.22 Bn | 58.15 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.43 Bn |
| Mar 31, 2026 | 1.34 Bn |
| Dec 31, 2025 | 1.17 Bn |
| Sep 30, 2025 | 2.93 Bn |
| Jun 30, 2025 | 3.01 Bn |
| Mar 31, 2025 | 3.06 Bn |
| Dec 31, 2024 | 2.04 Bn |
| Sep 30, 2024 | 1.66 Bn |
| Jun 30, 2024 | 970.71 Mn |
| Mar 31, 2024 | 808.42 Mn |
| Dec 31, 2023 | 1.85 Bn |
| Sep 30, 2023 | 1.54 Bn |
| Jun 30, 2023 | 1.81 Bn |
| Mar 31, 2023 | 2.27 Bn |
| Dec 31, 2022 | 1.94 Bn |
| Sep 30, 2022 | 2.16 Bn |
| Jun 30, 2022 | 2.07 Bn |
| Mar 31, 2022 | 2.90 Bn |
| Dec 31, 2021 | 4.59 Bn |
| Sep 30, 2021 | 8.47 Bn |